IL143149A0 - Stable, attenuated rabies virus mutants and live vaccines thereof - Google Patents

Stable, attenuated rabies virus mutants and live vaccines thereof

Info

Publication number: IL143149A0
Authority: IL; Israel
Prior art keywords: stable; rabies virus; live vaccines; virus mutants; attenuated rabies
Prior art date: 1998-11-27

Application number

IL14314999A

Other languages

English (en)

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-27

Filing date

1999-11-19

Publication date

2002-04-21

1999-11-19 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2002-04-21 Publication of IL143149A0 publication Critical patent/IL143149A0/xx

Links

241000711798 Rabies lyssavirus Species 0.000 title 1
230000002238 attenuated effect Effects 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20161—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IL14314999A 1998-11-27 1999-11-19 Stable, attenuated rabies virus mutants and live vaccines thereof IL143149A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98204001		1998-11-27
PCT/EP1999/009101 WO2000032755A1 (en)	1998-11-27	1999-11-19	Stable, attenuated rabies virus mutants and live vaccines thereof

Publications (1)

Publication Number	Publication Date
IL143149A0 true IL143149A0 (en)	2002-04-21

Family

ID=8234392

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14314999A IL143149A0 (en)	1998-11-27	1999-11-19	Stable, attenuated rabies virus mutants and live vaccines thereof
IL143149A IL143149A (en)	1998-11-27	2001-05-14	Stable mutants of rabies virus and live vaccines prepared from them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL143149A IL143149A (en)	1998-11-27	2001-05-14	Stable mutants of rabies virus and live vaccines prepared from them

Country Status (16)

Country	Link
US (1)	US6719981B1 (de)
EP (1)	EP1131414B1 (de)
AR (1)	AR021406A1 (de)
AT (1)	ATE356202T1 (de)
AU (1)	AU1386100A (de)
BR (1)	BR9915703B1 (de)
CA (1)	CA2352231C (de)
CY (1)	CY1106570T1 (de)
DE (1)	DE69935445T2 (de)
DK (1)	DK1131414T3 (de)
ES (1)	ES2283150T3 (de)
ID (1)	ID28968A (de)
IL (2)	IL143149A0 (de)
PT (1)	PT1131414E (de)
TR (1)	TR200101445T2 (de)
WO (1)	WO2000032755A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE316572T1 (de)	2001-04-23	2006-02-15	Akzo Nobel Nv	Attenuierte rekombinante stabile tollwutvirusmutanten und lebendimpfstoffe
EP1434862A4 (de)	2001-07-20	2005-04-06	Univ Georgia Res Found	Attenuiertes tollwutvirus mit einer nukleoproteinmutation an der phosphorylierungsstelle zur impfung gegen tollwut und gentherapie im zns
CA2943039C (en)	2005-10-14	2018-11-06	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention	Rabies virus compositions and methods
US7785874B2 (en) *	2007-01-11	2010-08-31	The Salk Institute For Biological Studies	Compositions and methods for monosynaptic transport
TW200907058A (en) *	2007-05-30	2009-02-16	Wyeth Corp	Raccoon poxvirus expressing rabies glycoproteins
WO2012106490A1 (en)	2011-02-03	2012-08-09	The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services	Multivalent vaccines for rabies virus and filoviruses
CN103865889B (zh) *	2014-04-03	2015-02-25	深圳市卫光生物制品股份有限公司	狂犬病病毒ctn鸡胚细胞适应株
EP3439695B1 (de)	2016-04-04	2022-05-04	The U.S.A. as represented by the Secretary, Department of Health and Human Services	Multivalente impfstoffe gegen tollwut- und coronaviren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2580176B1 (fr) *	1985-04-12	1988-02-26	Centre Nat Rech Scient	Vaccin antirabique avirulent
FR2633832B1 (fr) *	1988-07-05	1991-05-31	Virbac	Vaccin antirabique avirulent
FR2693655B1 (fr) *	1992-07-20	1994-10-14	Virbac	Vaccin antirabique avirulent.
SE0002498D0 (sv)	2000-07-03	2000-07-03	Stefan Schwartz	Papillomavirus vaccine
WO2003050398A1 (en)	2001-12-10	2003-06-19	Donaldson Company, Inc.	Exhaust treatment control system for an internal combustion engine
DE102004009653A1 (de)	2004-02-27	2005-09-22	Cycos Ag	Kommunikationsserver und Verfahren zum Aufbau und Betrieb einer Konferenz-Kommunikationsverbindung

1999
- 1999-11-19 IL IL14314999A patent/IL143149A0/xx active IP Right Grant
- 1999-11-19 WO PCT/EP1999/009101 patent/WO2000032755A1/en not_active Ceased
- 1999-11-19 ES ES99973064T patent/ES2283150T3/es not_active Expired - Lifetime
- 1999-11-19 PT PT99973064T patent/PT1131414E/pt unknown
- 1999-11-19 DK DK99973064T patent/DK1131414T3/da active
- 1999-11-19 TR TR2001/01445T patent/TR200101445T2/xx unknown
- 1999-11-19 BR BRPI9915703-9A patent/BR9915703B1/pt not_active IP Right Cessation
- 1999-11-19 AU AU13861/00A patent/AU1386100A/en not_active Abandoned
- 1999-11-19 EP EP99973064A patent/EP1131414B1/de not_active Expired - Lifetime
- 1999-11-19 CA CA2352231A patent/CA2352231C/en not_active Expired - Fee Related
- 1999-11-19 DE DE69935445T patent/DE69935445T2/de not_active Expired - Lifetime
- 1999-11-19 US US09/856,653 patent/US6719981B1/en not_active Expired - Lifetime
- 1999-11-19 AT AT99973064T patent/ATE356202T1/de active
- 1999-11-19 ID IDW00200101139A patent/ID28968A/id unknown
- 1999-11-26 AR ARP990106028A patent/AR021406A1/es not_active Application Discontinuation
2001
- 2001-05-14 IL IL143149A patent/IL143149A/en not_active IP Right Cessation
2007
- 2007-05-09 CY CY20071100622T patent/CY1106570T1/el unknown

Also Published As

Publication number	Publication date
US6719981B1 (en)	2004-04-13
IL143149A (en)	2007-12-03
CY1106570T1 (el)	2012-01-25
PT1131414E (pt)	2007-04-30
ID28968A (id)	2001-07-19
DK1131414T3 (da)	2007-06-18
AR021406A1 (es)	2002-07-17
BR9915703A (pt)	2001-08-14
ATE356202T1 (de)	2007-03-15
EP1131414B1 (de)	2007-03-07
AU1386100A (en)	2000-06-19
EP1131414A1 (de)	2001-09-12
BR9915703B1 (pt)	2012-09-04
CA2352231A1 (en)	2000-06-08
DE69935445D1 (de)	2007-04-19
CA2352231C (en)	2010-06-01
TR200101445T2 (tr)	2001-10-22
WO2000032755A1 (en)	2000-06-08
DE69935445T2 (de)	2007-11-29
ES2283150T3 (es)	2007-10-16

Legal Events

Date	Code	Title	Description
2008-04-13	FF	Patent granted
2008-06-05	KB	Patent renewed

Publication	Publication Date	Title
GB2337755B (en)	2003-10-29	Virus vaccine
HUP0103908A3 (en)	2003-10-28	Novel infulenza virus vaccine composition
AU3448797A (en)	1998-01-14	Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU5562798A (en)	1998-07-15	Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus.
AU6217798A (en)	1998-08-25	Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
EP1112091A4 (de)	2001-08-01	Schnelle tieftemperatur-drucksterilisation und impfstoffherstellung
ZA200201834B (en)	2004-04-28	Vaccine against HBV and HPV.
AU1508699A (en)	1999-06-16	Live attenuated influenza vaccine
IL140094A0 (en)	2002-02-10	Vaccine
ZA976815B (en)	1998-05-11	Vaccine composition.
IL153879A0 (en)	2003-07-31	Modified virus
HUP9701586A3 (en)	2001-06-28	Improved inactivated vaccines
IL137449A0 (en)	2001-07-24	Live vaccine against brucellosis
AU1386100A (en)	2000-06-19	Stable, attenuated rabies virus mutants and live vaccines thereof
GB9822714D0 (en)	1998-12-09	Vaccines
GB2344590B (en)	2000-11-08	Attenuated poliovirus vaccine
AU4957800A (en)	2000-12-18	Vaccine against isa virus
AU3487799A (en)	1999-11-01	Improved live attenuated viruses for use as vectors or vaccines
AU2144499A (en)	1999-08-09	Live attenuated salmonella vaccine
GB9702990D0 (en)	1997-04-02	Virus vaccine
IL149173A0 (en)	2002-11-10	Attenuated recombinant rabies virus mutants and live vaccines thereof
GB9927353D0 (en)	2000-01-19	Virus preparation and use
GB9620856D0 (en)	1996-11-27	Virus vaccine
GB9908224D0 (en)	1999-06-02	Virus preparations and methods
GB0023445D0 (en)	2000-11-08	Attenuated virus vaccine